1CNS Medical Affairs, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
Effective white blood cell monitoring systems significantly reduce the risk of clozapine-induced agranulocytosis, a serious side effect of this essential schizophrenia treatment. These programs ensure patient safety through regular blood tests and strict adherence to treatment guidelines.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: